The Neurochemistry of Autism

• Published in: Brain sciences Vol. 10; no. 3; p. 163
• Main Authors: Marotta, Rosa, Risoleo, Maria C, Messina, Giovanni, Parisi, Lucia, Carotenuto, Marco, Vetri, Luigi, Roccella, Michele
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 13-03-2020; MDPI
• Subjects: Acetylcholine; Acids; Anatomy; Arginine; Argipressin; Autism; autism spectrum disorder; Behavior; Brain; Cell adhesion & migration; Central nervous system; Comorbidity; Dopamine; Etiology; gaba; glutamate; Information processing; Intellectual disabilities; Melatonin; Mutation; n-acetyl aspartate; N-Acetylaspartate; Narcotics; neurochemistry; Neuropeptides; Neurotransmitters; Opinion; Opioid receptors (type delta); Orexins; Oxytocin; Researchers; Sensory integration; Serotonin; Spectrum analysis; Vasopressin; Vitamin D; γ-Aminobutyric acid; N-acetyl aspartate; oxytocin; serotonin; GABA; acetylcholine; neurochemistry; autism spectrum disorder; melatonin; dopamine; glutamate
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci10030163

Autism spectrum disorder (ASD) refers to complex neurobehavioral and neurodevelopmental conditions characterized by impaired social interaction and communication, restricted and repetitive patterns of behavior or interests, and altered sensory processing. Environmental, immunological, genetic, and epigenetic factors are implicated in the pathophysiology of autism and provoke the occurrence of neuroanatomical and neurochemical events relatively early in the development of the central nervous system. Many neurochemical pathways are involved in determining ASD; however, how these complex networks interact and cause the onset of the core symptoms of autism remains unclear. Further studies on neurochemical alterations in autism are necessary to clarify the early neurodevelopmental variations behind the enormous heterogeneity of autism spectrum disorder, and therefore lead to new approaches for the treatment and prevention of autism. In this review, we aim to delineate the state-of-the-art main research findings about the neurochemical alterations in autism etiology, and focuses on gamma aminobutyric acid (GABA) and glutamate, serotonin, dopamine, N-acetyl aspartate, oxytocin and arginine-vasopressin, melatonin, vitamin D, orexin, endogenous opioids, and acetylcholine. We also aim to suggest a possible related therapeutic approach that could improve the quality of ASD interventions. Over one hundred references were collected through electronic database searching in Medline and EMBASE (Ovid), Scopus (Elsevier), ERIC (Proquest), PubMed, and the Web of Science (ISI).